{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:16:11Z","timestamp":1778591771459,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7194272"],"award-info":[{"award-number":["7194272"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173057"],"award-info":[{"award-number":["82173057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060487"],"award-info":[{"award-number":["82060487"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.anndiagpath.2024.152321","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T05:08:26Z","timestamp":1714972106000},"page":"152321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinicopathological and molecular genetic analysis of 13 cases of primary retroperitoneal Ewing sarcoma"],"prefix":"10.1016","volume":"72","author":[{"given":"Xuejing","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2024.152321_bb0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-014-1627-1","article-title":"The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma","volume":"465","author":"Shibuya","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0010","first-page":"14","article-title":"The molecular biology of soft tissue sarcomas: current knowledge and future perspectives","author":"Vibert","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/gcc.22857","article-title":"The clinical heterogeneity of round cell sarcomas with EWSR1\/FUS gene fusions: impact of gene fusion type on clinical features and outcome","volume":"59","author":"Tsuda","year":"2020","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0020","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.humpath.2012.03.006","article-title":"Extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation associated with EWSR1(Ewing sarcoma breakpoint region 1)\/FLI1 translocation without prior chemotherapy","volume":"43","author":"Vali","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12894-023-01272-z","article-title":"Large retroperitoneal extraskeletal Ewing\u2019s sarcoma with renal pedicle invasion: a case report","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Urol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2022.107045","article-title":"Retroperitoneal blue cell round tumor (Ewing sarcoma in a 35 years old male)- case report","volume":"94","author":"Nedham","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7819-10-59","article-title":"Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstruction","volume":"10","author":"Bao","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canep.2014.12.012","article-title":"Prognostic factors for survival in patients with Ewing\u2019s sarcoma using the surveillance, epidemiology, and end results (SEER) program database","volume":"39","author":"Duchman","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2028910","article-title":"Ewing\u2019s sarcoma","volume":"384","author":"Riggi","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Gr\u00fcnewald","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2015.06.009","article-title":"An unusual retroperitoneal tumour mimicking adrenal pheochromocytoma","volume":"47","author":"Lu","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.asjsur.2021.12.009","article-title":"The giant retroperitoneal Extraosseous Ewing\u2019s sarcoma: a case report","volume":"45","author":"Chen","year":"2022","journal-title":"Asian J Surg"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2022.106966","article-title":"A case report of retroperitoneal Ewing sarcoma requiring adrenalectomy","volume":"95","author":"AlRashed","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00000478-200003000-00010","article-title":"Cytokeratin immunoreactivity in Ewing\u2019s sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies","volume":"24","author":"Gu","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12105-017-0830-1","article-title":"Usefulness of NKX2.2 immunohistochemistry for distinguishing Ewing sarcoma from other sinonasal small round blue cell tumors","volume":"12","author":"McCuiston","year":"2018","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2016.31","article-title":"Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma","volume":"29","author":"Hung","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13000-024-01443-y","article-title":"Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma","volume":"19","author":"Liu","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0090","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PAS.0b013e31828ff59d","article-title":"Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis","volume":"37","author":"Ishida","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/his.13689","article-title":"PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours","volume":"73","author":"Toki","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41379-018-0095-6","article-title":"PAX7 expression in sarcomas bearing the EWSR1-NFATC2 translocation","volume":"32","author":"Charville","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0105","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/modpathol.2017.49","article-title":"EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma","volume":"30","author":"Charville","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00428-018-2410-5","article-title":"Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens","volume":"473","author":"Fernandez-Pol","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0115","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/PAS.0000000000000717","article-title":"PAX7 expression in rhabdomyosarcoma, related soft tissue tumors, and small round blue cell neoplasms","volume":"40","author":"Charville","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0120","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1078-0432.CCR-0778-03","article-title":"Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor\/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis","volume":"10","author":"Gonz\u00e1lez","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0125","article-title":"Gastrointestinal Ewing sarcoma: a clinicopathological and molecular genetic analysis of 25 cases","author":"Yin","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/gcc.22336","article-title":"Ewing sarcoma with ERG gene rearrangements: a molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH","volume":"55","author":"Chen","year":"2016","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0135","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.3390\/cancers15245750","article-title":"EWSR1::ATF1 orchestrates the clear cell sarcoma transcriptome in human tumors and a mouse genetic model","volume":"15","author":"Ozenberger","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12957-021-02310-6","article-title":"Clinicopathological features of desmoplastic small round cell tumors: clinical series and literature review","volume":"19","author":"Wang","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0150","doi-asserted-by":"crossref","first-page":"884","DOI":"10.18632\/oncotarget.1021","article-title":"Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications","volume":"4","author":"Jiang","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/mutage\/8.3.199","article-title":"Regional mapping of human DNA excision repair gene ERCC4 to chromosome 16p13.13-p13.2","volume":"8","author":"Liu","year":"1993","journal-title":"Mutagenesis"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0160","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.7314\/APJCP.2014.15.18.7639","article-title":"Associations of ERCC4 rs1800067 polymorphism with cancer risk: an updated meta-analysis","volume":"15","author":"Yuan","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.951193","article-title":"Polymorphisms in ERCC4 and ERCC5 and risk of cancers: systematic research synopsis, meta-analysis, and epidemiological evidence","volume":"12","author":"Zuo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0170","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1038\/s41598-017-10333-x","article-title":"Germline mutations in Cancer predisposition genes are frequent in sporadic sarcomas","volume":"7","author":"Chan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0175","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12647","article-title":"Comprehensive analysis of ceRNA network of ERCC4 in colorectal cancer","volume":"9","author":"Hu","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102697","article-title":"Functional profiling of nucleotide excision repair in breast cancer","volume":"82","author":"Rajkumar-Calkins","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0185","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.7150\/jca.25814","article-title":"MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901\/DDP cells","volume":"10","author":"Xie","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0190","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(22)01790-1","article-title":"Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial","volume":"400","author":"Brennan","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0195","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/1078-0432.CCR-22-3546","article-title":"Longer versus shorter schedules of vincristine, irinotecan, and temozolomide (VIT) for relapsed or refractory Ewing sarcoma: a randomized controlled phase 2 trial","volume":"29","author":"Xu","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0200","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","article-title":"Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan clinical practice guideline for diagnosis, treatment and follow-up","volume":"32","author":"Strauss","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0205","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3390\/curroncol30070445","article-title":"Practical management of adult ultra-rare primary retroperitoneal soft tissue sarcoma: a focus on perivascular epithelioid tumours and extraosseous Ewing sarcoma","volume":"30","author":"Apte","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2011.5459","article-title":"Management of a large retroperitoneal primitive neuroectodermal tumour: \u2018a multimodal approach\u2019","volume":"2012","author":"Sable","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0215","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/iju.12546","article-title":"Pazopanib for recurrent extraosseous Ewing\u2019s sarcoma of the retroperitoneum","volume":"21","author":"Yamamoto","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0220","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.4081\/rt.2015.5992","article-title":"Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma","volume":"7","author":"Attia","year":"2015","journal-title":"Rare Tumors"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0225","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3109\/0284186X.2014.971938","article-title":"Response of refractory Ewing sarcoma to pazopanib","volume":"54","author":"Alcindor","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13691-019-00362-w","article-title":"Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma","volume":"8","author":"Tamura","year":"2019","journal-title":"Int Cancer Conf J"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0235","article-title":"Ewing sarcoma of the pelvis: clinical features and overall survival","volume":"33","author":"Brown","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.730292","article-title":"Characteristics and outcomes of locally recurrent retroperitoneal sarcoma after first relapse in a single tertiary Asian Centre and applicability of the sarculator","volume":"11","author":"Lim","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0245","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1002\/cncr.25840","article-title":"Clinical features and outcomes in patients with extraskeletal Ewing sarcoma","volume":"117","author":"Applebaum","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152321_bb0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13018-020-1571-5","article-title":"Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study","volume":"15","author":"Xie","year":"2020","journal-title":"J Orthop Surg Res"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:42:05Z","timestamp":1778589725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"alternative-id":["S1092913424000583"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152321","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological and molecular genetic analysis of 13 cases of primary retroperitoneal Ewing sarcoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152321"}}